Concepedia

Robert W. Akita

RW

Statistics

Publications

22

Citations

5.5K

H-Index

21

Active since

1989

Affiliations

Molecular Oncology (United States)(Current)

Genesys (United States)

Robert W. Akita is an author at Molecular Oncology (United States) specializing in molecular biology, life sciences, and cell signaling.

Publications per year

1989–2017

22

Publications

22

Identification of Heregulin, a Specific Activator of p185 <sup>erbB2</sup>

William E. Holmes, Mark X. Sliwkowski, Robert W. Akita et al. · Science · 1992 · 965 citations

, , +14

Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941

Teemu T. Junttila, Robert W. Akita, Kathryn L. Parsons et al. · Cancer Cell · 2009 · 831 citations · Full text

, , +14

Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.

Mark X. Sliwkowski, Gabriele Schaefer, Robert W. Akita et al. · Journal of Biological Chemistry · 1994 · 644 citations · Full text

, , +13

Spatial control of EGF receptor activation by reversible dimerization on living cells

Inhee Chung, Robert W. Akita, Richard Vandlen et al. · Nature · 2010 · 543 citations

, , +16

Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.

Michael F. Press, Malcolm C. Pike, V R Chazin et al. · PubMed · 1993 · 434 citations

, , +16

1–5 of 22